Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products to lower middle- and middle-income families in the United States. It operates in three segments: Life Insurance, Supplemental Health Insurance, and Investments.
Ver gráficos interactivos y estados completos → Modelo de valoración (DCF) →
| Cuenta de resultados | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos totales | $6.2B | $6.0B | $5.8B | $5.4B | $5.2B | $5.1B | $4.7B | $4.5B | $4.3B | $4.2B | $3.9B | $3.8B | $4.0B | $3.5B | $3.6B | $3.4B | $3.4B | $3.2B | $3.3B | $3.5B | $3.4B |
| Beneficio bruto | — | $2.0B | $1.9B | $1.6B | $4.9B | $4.8B | $4.4B | $4.2B | $4.0B | $3.9B | $1.1B | $1.1B | $3.7B | $1.0B | $1.0B | $1.0B | $1.0B | $3.0B | $3.1B | $1.2B | $1.2B |
| % de margen bruto | — | 33.4% | 32.4% | 30.1% | 93.2% | 93.7% | 93.7% | 93.3% | 93.5% | 93.8% | 27.6% | 28.3% | 94.4% | 30.0% | 29.1% | 29.7% | 29.8% | 94.6% | 94.4% | 34.2% | 34.5% |
| Ingresos operativos (EBIT) | — | $1.5B | $1.3B | $1.2B | $997M | $911M | $895M | $930M | $954M | $924M | $772M | $766M | $855M | $755M | $766M | $724M | $751M | $675M | $724M | $797M | $774M |
| % de margen operativo | — | 24.4% | 23.0% | 21.9% | 19.1% | 17.8% | 18.9% | 20.5% | 22.2% | 22.2% | 19.6% | 20.3% | 21.6% | 21.6% | 21.3% | 21.4% | 22.3% | 20.9% | 21.8% | 22.9% | 22.6% |
| Ingresos netos | $1.2B | $1.2B | $1.1B | $971M | $740M | $745M | $732M | $761M | $701M | $1.5B | $550M | $527M | $543M | $528M | $529M | $497M | $499M | $405M | $452M | $528M | $519M |
| % de margen neto | 19.6% | 19.4% | 18.5% | 17.8% | 14.2% | 14.6% | 15.4% | 16.8% | 16.3% | 35.0% | 14.0% | 14.0% | 13.7% | 15.1% | 14.8% | 14.7% | 14.8% | 12.6% | 13.6% | 15.1% | 15.2% |
| EBITDA | — | $1.6B | $1.5B | $1.3B | $997M | $911M | $895M | $930M | $954M | $915M | $856M | $843M | $855M | $836M | $847M | $802M | $826M | $675M | $724M | $1.3B | $1.2B |
| Beneficio por acción (EPS) | $15.06 | $14.36 | $12.63 | $10.07 | $7.47 | $7.22 | $6.82 | $6.83 | $6.08 | $12.22 | $4.49 | $4.16 | $4.09 | $3.79 | $3.60 | $3.02 | $2.70 | $2.17 | $2.27 | $2.45 | $2.28 |
| Acciones en circulación (M) | — | 81M | 85M | 96M | 99M | 103M | 107M | 111M | 115M | 119M | 122M | 127M | 133M | 140M | 147M | 165M | 185M | 187M | 199M | 216M | 227M |
Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.
Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de GL. /companies/us/GL
La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.
About TickerBase · Data methodology & sources · Privacy · Terms